Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Published on by Neuroscientists

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Jaleel Miyan | Clinical Neuroscience | Best Researcher Award

Dr. Jaleel Miyan | The University of Manchester | United Kingdom

Dr. Jaleel Ahmad Miyan is a distinguished British neuroscientist and Senior Lecturer at the Faculty of Biology, Medicine & Health, Division of Neuroscience, University of Manchester, with a long-standing career dedicated to understanding cerebrospinal fluid (CSF) physiology and its role in neurological disorders. As President of the Society for Research into Hydrocephalus & Spina Bifida and a Fellow of both the Higher Education Academy and the Royal Society of Biology, he is recognized internationally for his expertise in cerebral folate metabolism and hydrocephalus research. His principal work focuses on fetal-onset and neonatal hydrocephalus, aiming to develop a non-invasive, non-surgical treatment to address global disparities in care. Miyan has supervised numerous PhD and Masters students, postdoctoral researchers, and technicians, fostering research excellence. He has published over 120 peer-reviewed research papers and reviews, with an h-index of 34, and his work has garnered substantial citations, reflecting his impact in neuroscience. He has served on editorial boards, contributed to major research projects, and secured significant funding for studies on folate metabolism in neurological conditions. Miyan’s scholarship is accessible through his ResearchGate, Orcid, and Google Scholar profiles, showcasing his profound contributions to advancing neuroscience and improving treatments for devastating neurological conditions.

Profiles : Google Scholar | Orcid | Research Gate

Featured Publications

Downing, J. E. G., & Miyan, J. A. (2000). Neural immunoregulation: Emerging roles for nerves in immune homeostasis and disease. Immunology Today, 21(6), 281–289.

Assas, B. M., Pennock, J. I., & Miyan, J. A. (2014). Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Frontiers in Neuroscience, 8, 23.

Miyan, J. A., Nabiyouni, M., & Zendah, M. (2003). Development of the brain: A vital role for cerebrospinal fluid. Canadian Journal of Physiology and Pharmacology, 81(4), 317–328.

Gazi, E., Dwyer, J., Lockyer, N. P., Miyan, J., Gardner, P., Hart, C., & Brown, M., et al. (2005). Fixation protocols for subcellular imaging by synchrotron‐based Fourier transform infrared microspectroscopy. Biopolymers: Original Research on Biomolecules, 77(1), 18–30.

Mashayekhi, F., Draper, C. E., Bannister, C. M., Pourghasem, M., & Miyan, J. A., et al. (2002). Deficient cortical development in the hydrocephalic Texas (H‐Tx) rat: A role for CSF. Brain, 125(8), 1859–1874.

Owen‐Lynch, P. J., Draper, C. E., Mashayekhi, F., Bannister, C. M., & Miyan, J. A. (2003). Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain, 126(3), 623–631.

Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Published on by Neuroscientists

Prof. Dr. Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Prof. Dr. Junliang Yuan | Peking University Sixth Hospital | China

Dr. Junliang Yuan is a neurologist, Associate Professor, and Director of the Department of Neurology at Peking University Sixth Hospital, Beijing, China. He earned his Bachelor’s degree in Clinical Medicine from Jining Medical College, a Master’s in Neurology from Dalian Medical University, and a Medical Degree in Neurology from Capital Medical University, followed by a postdoctoral fellowship at McLean Hospital/Harvard Medical School. He has also served as Associate Professor of Neurology at Beijing Chaoyang Hospital. Dr. Yuan’s research focuses on neuropsychiatric disorders, neurodegenerative diseases, cognition and dementia, movement disorders including Parkinson’s disease, and sleep disorders. He has secured multiple prestigious research grants, including funding from the Science and Technology Innovation 2030 “Brain Science and Brain-like Research” major project, the National Natural Science Foundation of China, the Chinese Academy of Sciences, and several Beijing Municipal health research programs. His scholarly output includes 91 published documents, which have been cited 1,585 times by 1,508 other publications, reflecting his influence in the field with an h-index of 22. Through his leadership and research, Dr. Yuan continues to contribute significantly to advancing clinical and translational neuroscience, with a strong focus on improving the diagnosis, management, and treatment of neurological disorders.

Profiles: Scopus | Google Scholar | Research Gate | Linked In | Staff Page

Featured Publications

Li, Y., Li, M., Zhang, X., Shi, Q., Yang, S., Fan, H., Qin, W., Yang, L., Yuan, J., Jiang, T., … (2017). Higher blood–brain barrier permeability is associated with higher white matter hyperintensities burden. Journal of Neurology, 264(7), 1474–1481.

Yuan, J., Yang, S., Wang, S., Qin, W., Yang, L., & Hu, W. (2017). Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults: A case report and literature review. BMC Neurology, 17(1), 103.

Li, Y., Li, M., Yang, L., Qin, W., Yang, S., Yuan, J., Jiang, T., & Hu, W. (2019). The relationship between blood–brain barrier permeability and enlarged perivascular spaces: A cross-sectional study. Clinical Interventions in Aging, 14, 871–878.

Chen, Y., Zhang, J., Wang, Y., Yuan, J., & Hu, W. (2016). Efficacy of cholinesterase inhibitors in vascular dementia: An updated meta-analysis. European Neurology, 75(3–4), 132–141.

Li, X., Yuan, J., Liu, L., & Hu, W. (2019). Antibody-LGI1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: A case report and literature review. BMC Neurology, 19(1), 19.

Zhang, X., Ding, L., Yang, L., Qin, W., Yuan, J., Li, S., & Hu, W. (2016). Brain atrophy correlates with severe enlarged perivascular spaces in basal ganglia among lacunar stroke patients. PLoS ONE, 11(2), e0149593.

Li, X., Yuan, J., Yang, L., Qin, W., Yang, S., Li, Y., Fan, H., & Hu, W. (2017). The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis. PLoS ONE, 12(9), e0185145.

Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Mrs. Rezvan Ghafarzadegan | Tarbiat Modares University | Iran

Rezvan Ghafarzadegan is a distinguished nursing scholar specializing in Medical-Surgical Education, holding an M.Sc. in Nursing from Tehran University of Medical Sciences and a B.Sc. in Nursing from Arak University of Medical Sciences, both completed with exceptional academic honors and outstanding GPAs. She is currently a Ph.D. candidate in Nursing at Tarbiat Modares University, demonstrating a strong commitment to advancing nursing education and clinical practice. Rezvan has extensive teaching experience, serving as an instructor for Medical-Surgical Nursing, Emergency Medicine, Internal Diseases, Medical Ethics, Pathophysiology, Orthopedic Surgical Technology, and Introduction to Surgical Technology. She also has broad clinical instruction expertise in Emergency, Internal Medicine (Gastroenterology & Endocrinology), Orthopedics, Neurosurgery, and General Surgery, along with operating room education. Her scholarly contributions include 9 published documents that have collectively earned 31 citations, reflecting her growing impact in the field, and she holds an h-index of 3. Recognized throughout her academic journey as an exceptional talent student, Rezvan combines clinical expertise with a deep dedication to research, striving to improve nursing education and patient care through both her teaching and scientific endeavors.

Profiles: Scopus | Orcid | Research gate

Featured Publications

Zarei, M., Norouzi, N., Teymoori, E., & Ghafarzadegan, R. (2025). Covering sterile instrument tables to prevent airborne bacterial contamination and surgical wound infections: A narrative review of operating room nursing practices. Perioperative Care and Operating Room Management, 100495.

Ghafarzadegan, R., Zarei, M., Norouzi, N., Mirbagher Ajorpaz, N., Lotfi, S. M., Rasooli Manesh, S. M., Akbari, H., & Abedi, A. (2025). Efficacy of an Iranian herbal medicine formula for postoperative constipation in trauma patients with hip and lower limb fractures: A triple-blind, placebo-controlled randomized clinical trial. International Journal of Orthopaedic and Trauma Nursing, 101163.

Javaheri, J., Asgari, M., & Ghafarzadegan, R. (2023). The effect of Nigella sativa powder on blood sugar and lipid profiles in type 2 diabetic patients. Jundishapur Journal of Natural Pharmaceutical Products, e135757.

Gang Cao | Behavioral Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Gang Cao | Behavioral Neuroscience | Best Researcher Award

Anhui University of Finance and Economics | China

Gang Cao (Ph.D.) is a Lecturer at the International Business School, Anhui University of Finance and Economics, with academic training in Business Administration and Management Science and Engineering from Shanghai University and Anhui University of Finance and Economics. His research focuses on AI capabilities, entrepreneurship, and innovation, and he has published in leading international journals such as the Journal of Business Research, Management and Organization Review, R&D Management, Plos One, and the International Journal of Conflict Management, as well as in top Chinese journals including Journal of Management Sciences in China and Journal of Economic Management. He has authored and co-authored multiple high-impact studies addressing themes such as entrepreneurial well-being, entrepreneurial failure and reentry, bricolage and disruptive innovation, digital identity change, impression management, and the integration of artificial intelligence with entrepreneurship and business model innovation. His work combines quantitative, qualitative, and computational methodologies, offering both theoretical contributions and practical insights into entrepreneurial behavior and firm evolution. Gang Cao has achieved an h-index of 5, with 11 documents and 102 citations, reflecting his growing academic impact and recognition in the fields of entrepreneurship, innovation management, and digital transformation. Through his interdisciplinary and collaborative research, he continues to advance understanding of the complex dynamics driving entrepreneurial success and organizational performance.

Profiles: Google Scholar

Featured Publications

“Exploring the relationship between entrepreneurial failure and conflict between work and family from the conservation of resources perspective.”

“Entrepreneurial Bricolage and Disruptive Innovation: The Joint Effect of Learning From Failure and Institutional voids.”

“Striking the balance: Configurations of causation and effectuation principles for SME performance.”